Evaluation of Ganovo Combined With Ritonavir in the Treatment of Novel Coronavirus Infection
Condition:   2019-nCoV Pneumonia Interventions:   Drug: Ganovo+ritonavir with or without interferon atomization;   Drug: Pegasys;   Drug: Novaferon atomization;   Drug: Lopinavir+ritonavir;   Drug: Chinese medicines +interferon atomization Sponsors:   The Ninth Hospital of Nanchang;   Ascletis Pharmaceuticals Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials

Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis
Conditions:   Hepatitis B;   Liver Fibrosis Interventions:   Drug: Tenofovir Disoproxil Fumarate;   Drug: PEG-Interferon alfa 2a Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2019 Category: Research Source Type: clinical trials

Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis
Conditions:   Hepatitis B;   Liver Fibrosis Interventions:   Drug: Tenofovir Disoproxil Fumarate;   Drug: Peginterferon Alfa-2a;   Drug: Peginterferon Alfa-2b Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2019 Category: Research Source Type: clinical trials

Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
Conditions:   Hepatitis B;   Liver Fibrosis Interventions:   Drug: Tenofovir Disoproxil Fumarate;   Drug: Peginterferon Alfa-2a;   Drug: Peginterferon Alfa-2b Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Phase 2b Study to Assess Efficacy and Safety of Bulevirtide With Peginterferon Alfa-2a in Patients With CHD
Condition:   Hepatitis D, Chronic Interventions:   Drug: Bulevirtide;   Drug: Peginterferon Alfa-2a Sponsors:   MYR GmbH;   Hepatera Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2019 Category: Research Source Type: clinical trials

Phase 2b Study of Bulevirtide (With Peginterferon Alfa-2a) in Patients With CHD
Condition:   Hepatitis D, Chronic Interventions:   Drug: Bulevirtide;   Drug: Peginterferon Alfa-2a Sponsors:   MYR GmbH;   Hepatera Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2019 Category: Research Source Type: clinical trials

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Condition:   Hepatitis B Virus Interventions:   Biological: Human Serum Albumin/interferon alpha2b fusion protein;   Biological: Pegasys Sponsor:   Tianjin SinoBiotech Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2017 Category: Research Source Type: clinical trials